New daily persistent headache

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Purpose of Review: The entity of new daily persistent headache is a recognized form of chronic daily headache with a unique clinical presentation. This review will discuss the clinical characteristics, triggering factors, possible underlying pathogenesis and treatment options for this syndrome. It will also discuss the issues with the current International Classification of Headache Disorders criteria for new daily persistent headache and suggest revised criteria. The medical literature relating to new daily persistent headache is scant so most of what is presented is a personal view by the author who has extensive clinical experience with this syndrome. Recent Findings: There is recent interest in the possible role of tumor necrosis factor α in new daily persistent headache pathogenesis and how a history of cervical spine hypermobility may be a needed predisposing physical characteristic for the development of this condition. Summary: New daily persistent headache is a recognized form of primary headache. It is unique in its presentation and course. Many new daily persistent headache patients can state the exact date their headache began. New daily persistent headache is marked by a continuous daily head pain of varying intensity, which can be associated with migrainous symptoms. At present, prognosis for new daily persistent headache is recognized as poor with very few available effective treatment options. The current International Classification of Headache Disorders 2 criteria for new daily persistent headache is inadequate and needs to be revised to capture a significant number of patients with this condition that would not meet the current published criteria.

Original languageEnglish (US)
Pages (from-to)211-216
Number of pages6
JournalCurrent Opinion in Neurology
Volume24
Issue number3
DOIs
StatePublished - Jun 1 2011
Externally publishedYes

Fingerprint

Headache
Headache Disorders
Spine
Tumor Necrosis Factor-alpha

Keywords

  • cervical hypermobility
  • chronic daily headache
  • new daily persistent headache
  • tumor necrosis factor alpha

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

New daily persistent headache. / Rozen, Todd.

In: Current Opinion in Neurology, Vol. 24, No. 3, 01.06.2011, p. 211-216.

Research output: Contribution to journalArticle

Rozen, Todd. / New daily persistent headache. In: Current Opinion in Neurology. 2011 ; Vol. 24, No. 3. pp. 211-216.
@article{2e8d270ade3542eb9eb7322b92f8e53e,
title = "New daily persistent headache",
abstract = "Purpose of Review: The entity of new daily persistent headache is a recognized form of chronic daily headache with a unique clinical presentation. This review will discuss the clinical characteristics, triggering factors, possible underlying pathogenesis and treatment options for this syndrome. It will also discuss the issues with the current International Classification of Headache Disorders criteria for new daily persistent headache and suggest revised criteria. The medical literature relating to new daily persistent headache is scant so most of what is presented is a personal view by the author who has extensive clinical experience with this syndrome. Recent Findings: There is recent interest in the possible role of tumor necrosis factor α in new daily persistent headache pathogenesis and how a history of cervical spine hypermobility may be a needed predisposing physical characteristic for the development of this condition. Summary: New daily persistent headache is a recognized form of primary headache. It is unique in its presentation and course. Many new daily persistent headache patients can state the exact date their headache began. New daily persistent headache is marked by a continuous daily head pain of varying intensity, which can be associated with migrainous symptoms. At present, prognosis for new daily persistent headache is recognized as poor with very few available effective treatment options. The current International Classification of Headache Disorders 2 criteria for new daily persistent headache is inadequate and needs to be revised to capture a significant number of patients with this condition that would not meet the current published criteria.",
keywords = "cervical hypermobility, chronic daily headache, new daily persistent headache, tumor necrosis factor alpha",
author = "Todd Rozen",
year = "2011",
month = "6",
day = "1",
doi = "10.1097/WCO.0b013e328345c5ad",
language = "English (US)",
volume = "24",
pages = "211--216",
journal = "Current Opinion in Neurology",
issn = "1350-7540",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - New daily persistent headache

AU - Rozen, Todd

PY - 2011/6/1

Y1 - 2011/6/1

N2 - Purpose of Review: The entity of new daily persistent headache is a recognized form of chronic daily headache with a unique clinical presentation. This review will discuss the clinical characteristics, triggering factors, possible underlying pathogenesis and treatment options for this syndrome. It will also discuss the issues with the current International Classification of Headache Disorders criteria for new daily persistent headache and suggest revised criteria. The medical literature relating to new daily persistent headache is scant so most of what is presented is a personal view by the author who has extensive clinical experience with this syndrome. Recent Findings: There is recent interest in the possible role of tumor necrosis factor α in new daily persistent headache pathogenesis and how a history of cervical spine hypermobility may be a needed predisposing physical characteristic for the development of this condition. Summary: New daily persistent headache is a recognized form of primary headache. It is unique in its presentation and course. Many new daily persistent headache patients can state the exact date their headache began. New daily persistent headache is marked by a continuous daily head pain of varying intensity, which can be associated with migrainous symptoms. At present, prognosis for new daily persistent headache is recognized as poor with very few available effective treatment options. The current International Classification of Headache Disorders 2 criteria for new daily persistent headache is inadequate and needs to be revised to capture a significant number of patients with this condition that would not meet the current published criteria.

AB - Purpose of Review: The entity of new daily persistent headache is a recognized form of chronic daily headache with a unique clinical presentation. This review will discuss the clinical characteristics, triggering factors, possible underlying pathogenesis and treatment options for this syndrome. It will also discuss the issues with the current International Classification of Headache Disorders criteria for new daily persistent headache and suggest revised criteria. The medical literature relating to new daily persistent headache is scant so most of what is presented is a personal view by the author who has extensive clinical experience with this syndrome. Recent Findings: There is recent interest in the possible role of tumor necrosis factor α in new daily persistent headache pathogenesis and how a history of cervical spine hypermobility may be a needed predisposing physical characteristic for the development of this condition. Summary: New daily persistent headache is a recognized form of primary headache. It is unique in its presentation and course. Many new daily persistent headache patients can state the exact date their headache began. New daily persistent headache is marked by a continuous daily head pain of varying intensity, which can be associated with migrainous symptoms. At present, prognosis for new daily persistent headache is recognized as poor with very few available effective treatment options. The current International Classification of Headache Disorders 2 criteria for new daily persistent headache is inadequate and needs to be revised to capture a significant number of patients with this condition that would not meet the current published criteria.

KW - cervical hypermobility

KW - chronic daily headache

KW - new daily persistent headache

KW - tumor necrosis factor alpha

UR - http://www.scopus.com/inward/record.url?scp=79955626575&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955626575&partnerID=8YFLogxK

U2 - 10.1097/WCO.0b013e328345c5ad

DO - 10.1097/WCO.0b013e328345c5ad

M3 - Article

C2 - 21455069

AN - SCOPUS:79955626575

VL - 24

SP - 211

EP - 216

JO - Current Opinion in Neurology

JF - Current Opinion in Neurology

SN - 1350-7540

IS - 3

ER -